The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PemBOv trial: Pembrolizumab plus bevacizumab with or without pegylated liposomal doxorubicin-based chemotherapy in patients with platinum-resistant ovarian cancer.
 
Judith Michels
Consulting or Advisory Role - GlaxoSmithKline
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo Europe GmbH; Gilead Sciences; GlaxoSmithKline; Lilly; Novartis; Novocure; Pfizer; Pierre Fabre; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; Novartis; Pfizer; Roche; Seagen
 
Caroline Brard
No Relationships to Disclose
 
Catherine Genestie
No Relationships to Disclose
 
Corinne Balleyguier
No Relationships to Disclose
 
Joseph Ciccolini
Honoraria - Daiichi Sankyo Europe GmbH; Eisai; Pierre Fabre; Roche (Inst); Roche/Genentech
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche
 
Angelo Paci
Stock and Other Ownership Interests - Findimmune
Patents, Royalties, Other Intellectual Property - Patents in Gustave Roussy Transfert
Travel, Accommodations, Expenses - Pierre Fabre
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech
 
Anne Floquet
No Relationships to Disclose
 
Lauriane Eberst
No Relationships to Disclose
 
Rastilav Bahleda
No Relationships to Disclose
 
Patricia Pautier
Consulting or Advisory Role - AstraZeneca (Inst); MSD Oncology (Inst); MSD vaccin (Inst); Onxeo (Inst); PharmaMar (Inst)
Research Funding - Onxeo (Inst); PharmaMar (Inst)
Expert Testimony - Clovis Oncology (Inst); Onxeo (Inst); Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD Oncology; OSE Immunotherapeutics; Roche
 
Emeline Colomba
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Pfizer; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Pfizer
 
Fanny Pommeret
No Relationships to Disclose
 
Christophe Massard
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Blueprint Medicines; BMS; Celgene; Debiopharm Group; Faron Pharmaceuticals; Faron Pharmaceuticals; Faron Pharmaceuticals; Faron Pharmaceuticals; Faron Pharmaceuticals; Genentech/Roche; INNATE PHARMA; IPSEN; Janssen; Lilly; MSD; Novartis; ORION; Pfizer; PharmaMar; Sanofi; Taiho Pharmaceutical
 
Aurelien Marabelle
Stock and Other Ownership Interests - Centessa Pharmaceuticals; Centessa Pharmaceuticals (Inst); Deka Biosciences; HiFiBiO Therapeutics; HotSpot Therapeutics; PEGASCY (Inst); Shattuck Labs
Consulting or Advisory Role - AstraZeneca; BiolineRx; Centessa Pharmaceuticals; Clover Biopharmaceuticals; Deka Biosciences; Depth Charge Therapeutics; Eisai; Gritstone Bio; HiFiBiO Therapeutics; Hotspot Therapeutics; ImCheck therapeutics; Innate Pharma; Johnson & Johnson/Janssen; Lytix Biopharma; Medicxi; MedinCell; MSD; OSE Immunotherapeutics; Pierre Fabre; Redx Pharma; Roche; SERVIER; Shattuck Labs; Sotio; Third Rock Ventures
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Transgene (Inst)
Patents, Royalties, Other Intellectual Property - monoclonal antibodies against CD81 (Stanford University)
Travel, Accommodations, Expenses - Sotio
 
Alexandra Leary
Honoraria - Medscape
Consulting or Advisory Role - AstraZeneca (Inst); Blueprint Medicines (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Merck Serono (Inst); MSD (Inst); PEGASCY; Tesaro (Inst); zentalis
Research Funding - Inivata (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro